National Cancer Institute; Notice of Closed Meetings, 12267 [2019-06231]

Download as PDF Federal Register / Vol. 84, No. 62 / Monday, April 1, 2019 / Notices Dated: March 26, 2019. Melanie J. Pantoja, Program Analyst, Office of Federal Advisory Committee Policy. DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health [FR Doc. 2019–06231 Filed 3–29–19; 8:45 am] National Cancer Institute; Notice of Closed Meetings BILLING CODE 4140–01–P Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI Program Project I (P01). Date: May 16–17, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda North Marriott Hotel & Conference Center, 5701 Marinelli Road, North Bethesda, MD 20852. Contact Person: Sanita Bharti, Ph.D., Scientific Review Officer, Research Program Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W122, Bethesda, MD 20892–9750, 240–276–5909, sanitab@mail.nih.gov. Name of Committee: National Cancer Institute Special Emphasis Panel; NCI U54 Immuno-engineering to Improve Immunotherapy (i3) Centers Review. Date: June 19–20, 2019. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville Hotel, 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Majed M. Hamawy, Ph.D., Scientific Review Officer, Resources and Training Review Branch, Division of Extramural Activities, National Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W120, Bethesda, MD 20892–9750, 240–276–6457, mh101v@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) VerDate Sep<11>2014 17:22 Mar 29, 2019 Jkt 247001 DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration (SAMHSA) Advisory Committee for Women’s Services (ACWS); Notice of Meeting Pursuant to Public Law 92–463, notice is hereby given of a meeting of the Substance Abuse and Mental Health Services Administration’s (SAMHSA) Advisory Committee for Women’s Services (ACWS) on May 29, 2019. The meeting will include discussions on assessing SAMHSA’s current strategies, including the mental health and substance use needs of the pregnant and parenting women population. Additionally, the ACWS will be speaking with the Assistant Secretary for Mental Health and Substance Use regarding priorities and directions around behavioral health services and access for women and children. The meeting is open to the public and will be held virtually only (not in person), by SAMHSA, 5600 Fishers Lane, Rockville, MD 20857. Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions should be forwarded to the contact person (below) by May 15, 2019. Oral presentations from the public will be scheduled at the conclusion of the meeting. Individuals interested in making oral presentations must notify the contact person on or before May 15, 2019. Five minutes will be allotted for each presentation. The meeting may be accesed via telephone or WebEx. To obtain the callin number and access code, submit written or brief oral comments, or request special accommodations for persons with disabilities, please register on-line at https:// snacregister.samhsa.gov/ MeetingList.aspx, or communicate with SAMHSA’s Designated Federal Officer, Ms. Valerie Kolick (see contact information below). Substantive meeting information and a roster of ACWS members may be obtained either by accessing the SAMHSA Committees’ Web https:// www.samhsa.gov/about-us/advisorycouncils/meetings, or by contacting Ms. Kolick. PO 00000 Frm 00078 Fmt 4703 Sfmt 4703 12267 Committee Name: Substance Abuse and Mental Health Services Administration, Advisory Committee for Women’s Services (ACWS). Date/Time/Type: Wednesday, May 29, 2019, from: 9:00 a.m. to 3:45 p.m. EDT. Open. Place: Virtual and phone meeting only. Contact: Valerie Kolick, Designated Federal Official, SAMHSA’s Advisory Committee for Women’s Services, 5600 Fishers Lane, Rockville, MD 20857, Telephone: (240) 276–1738, Email: Valerie.kolick@samhsa.hhs.gov. Dated: March 27, 2019. Carlos Castillo, Committee Management Officer, Substance Abuse and Mental Health, Services Administration. [FR Doc. 2019–06255 Filed 3–29–19; 8:45 am] BILLING CODE 4162–20–P DEPARTMENT OF HOMELAND SECURITY Coast Guard [Docket No. USCG–2018–1085] RIN 1625–AA09 Extension of Comment Period for the Draft Environmental Assessment for the Proposed Construction of Railroad Bridges Across Sand Creek and Lake Pend Oreille at Sandpoint, Bonner County, Idaho Coast Guard, DHS. Extension of comment period. AGENCY: ACTION: The United States Coast Guard is extending the comment period for the draft Environmental Assessment (EA) which appeared in the Federal Register on February 6, 2019 for the proposed construction of railroad bridges across Lake Pend Oreille and Sand Creek at Sandpoint, Bonner County, Idaho. The draft EA addresses environmental impacts and socioeconomic effects related to the proposed construction of railroad bridges built parallel to existing bridges crossing the same waterbodies. The comment period has been extended an additional 30 days to May 1, 2019. DATES: Comments and related material must be submitted to the online docket at https://www.regulations.gov or reach the Docket Management Facility on or before May 1, 2019. ADDRESSES: You may submit comments identified by docket number USCG– 2018–1085 using the Federal eRulemaking Portal at https:// www.regulations.gov. The direct link to SUMMARY: E:\FR\FM\01APN1.SGM 01APN1

Agencies

[Federal Register Volume 84, Number 62 (Monday, April 1, 2019)]
[Notices]
[Page 12267]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-06231]



[[Page 12267]]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Cancer Institute; Notice of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI Program Project I (P01).
    Date: May 16-17, 2019.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda North Marriott Hotel & Conference Center, 5701 
Marinelli Road, North Bethesda, MD 20852.
    Contact Person: Sanita Bharti, Ph.D., Scientific Review Officer, 
Research Program Review Branch, Division of Extramural Activities, 
National Cancer Institute, NIH, 9609 Medical Center Drive, Room 
7W122, Bethesda, MD 20892-9750, 240-276-5909, [email protected].

    Name of Committee: National Cancer Institute Special Emphasis 
Panel; NCI U54 Immuno-engineering to Improve Immunotherapy (i3) 
Centers Review.
    Date: June 19-20, 2019.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville Hotel, 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Majed M. Hamawy, Ph.D., Scientific Review 
Officer, Resources and Training Review Branch, Division of 
Extramural Activities, National Cancer Institute, NIH, 9609 Medical 
Center Drive, Room 7W120, Bethesda, MD 20892-9750, 240-276-6457, 
[email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated: March 26, 2019.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2019-06231 Filed 3-29-19; 8:45 am]
 BILLING CODE 4140-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.